Status:
COMPLETED
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
Lead Sponsor:
University of Pittsburgh
Conditions:
Bacteremia
Pseudomonas Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
More than 80 patients at the University of Pittsburgh Medical Center have been infected with Pseudomonas aeruginosa, lacking susceptibility to all commercially available antibiotics except "colistin"....
Detailed Description
At baseline (upon signing informed consent), the following information will be collected: Demographic data - age, sex, height, weight, state of birth, underlying illnesses, underlying infection, immun...
Eligibility Criteria
Inclusion
- Males or females greater than 18 years of age.
- All patients will remain in the hospital for pharmacokinetic sampling.
- All subjects must be on the medication colistin as part of their standard of care.
- All individuals approached for participation shall be able to read and comprehend English.
Exclusion
- None
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00235690
Start Date
June 1 2008
End Date
August 1 2015
Last Update
December 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213